← Leaderboards
Jeffrey Michael Karp
Brigham And Women'S Hospital
$7,701,091
Attributed
$9,411,591
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,411,591 · 8
By mechanism
R01$7,526,093 · 3
R21$1,426,647 · 3
R03$258,850 · 1
R56$200,001 · 1
Top collaborators
- Amit Choudhary3 shared
- Neal Krishna Devaraj3 shared
- Rohit N. Kulkarni3 shared
- Nitin Joshi2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Ali Tamayol$3,768,258
- Dino J Ravnic$3,516,424
- Robert Sackstein$20,708,410
- Su Ryon Shin$3,920,565
- Reza Abdi$32,829,278
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoIn VitroEngineeringTissuesInflammationResponsePublic Health RelevancePropertySurfaceModificationCellsStem CellsMouse ModelAffectLigandsSiteMediatingAdhesionsMesenchymal Stem CellsInterestExhibitsWound HealingBaseResearch Study
Grant awards (26)
Development of platforms for sorting, production, editing of beta cells$651,811
R01 · FY2025 · DK
Development of platforms for sorting, production, editing of beta cells$623,544
R01 · FY2024 · DK
Surmounting substance use disorder using an ultra-long acting injectable platform.$214,902
R21 · FY2024 · DA
Development of platforms for sorting, production, editing of beta cells$691,470
R01 · FY2023 · DK
Surmounting substance use disorder using an ultra-long acting injectable platform.$255,860
R21 · FY2023 · DA
Engineered Induction of a Stem Cell Homing Response$443,750
R01 · FY2018 · HL · contact PI
Engineered Induction of a Stem Cell Homing Response$443,750
R01 · FY2017 · HL · contact PI
Engineered Induction of a Stem Cell Homing Response$443,750
R01 · FY2016 · HL · contact PI
Engineered Induction of a Stem Cell Homing Response$443,645
R01 · FY2015 · HL · contact PI
Engineered Induction of a Stem Cell Homing Response$399,510
R01 · FY2014 · HL · contact PI
Biomedical adhesives with precisely engineered surface topography and chemistry$343,040
R01 · FY2014 · GM · contact PI
Targeting mucositis with inflammation responsive hydrogel microparticles$265,125
R21 · FY2014 · DE · contact PI
Engineered Induction of a Stem Cell Homing Response$388,529
R01 · FY2013 · HL · contact PI
Biomedical adhesives with precisely engineered surface topography and chemistry$332,781
R01 · FY2013 · GM · contact PI
Targeting mucositis with inflammation responsive hydrogel microparticles$220,313
R21 · FY2013 · DE · contact PI
A Drug Delivery Platform For Near-Term Treatment of Proteolytic Disease$200,001
R56 · FY2013 · AR · contact PI
Engineered Induction of a Stem Cell Homing Response$415,939
R01 · FY2012 · HL · contact PI
Biomedical adhesives with precisely engineered surface topography and chemistry$345,648
R01 · FY2012 · GM · contact PI
Engineered Induction of a Stem Cell Homing Response$426,201
R01 · FY2011 · HL · contact PI
Biomedical adhesives with precisely engineered surface topography and chemistry$339,319
R01 · FY2011 · GM · contact PI
Examining firm adhesion and transmigration of surface engineered MSCs$202,911
R21 · FY2011 · HL · contact PI
Engineered Induction of a Stem Cell Homing Response$453,907
R01 · FY2010 · HL · contact PI
Biomedical adhesives with precisely engineered surface topography and chemistry$339,499
R01 · FY2010 · GM · contact PI
Examining firm adhesion and transmigration of surface engineered MSCs$267,536
R21 · FY2010 · HL · contact PI
Characterization of endogenous stem cells within endosseous wounds$129,600
R03 · FY2010 · DE · contact PI
Characterization of endogenous stem cells within endosseous wounds$129,250
R03 · FY2009 · DE · contact PI